ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
US Tech 100
20,762.73
1.73%
Dow Jones
42,732.13
0.80%
Brent Oil
76.495
0.00%
Bitcoin
98,322.98
0.12%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Finseta Plc (FIN) Quote

Finseta Plc

Finseta Plc (FIN)

Fin Resources Limited
Grit Metals Corp
38.50
0.10
(0.26%)
Closed January 05 11:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
38.50
Bid
38.00
Ask
39.00
Volume
633,866
37.00 Day's Range 40.50
25.00 52 Week Range 43.50
Market Cap
22.106M
Previous Close
38.40
Open
37.00
Last Trade
45000
@
38.5
(O)
Last Trade Time
Financial Volume
247,208p
VWAP
39.00
Average Volume (3m)
117,823
Shares Outstanding
57,417,101
Dividend Yield
-
PE Ratio
10.35
Earnings Per Share (EPS)
0.04
Revenue
9.65M
Net Profit
2.13M

About Finseta Plc

Sector
Catalog, Mail-order Houses
Industry
Catalog, Mail-order Houses
Website
finseta.com/
Headquarters
London, Gbr
Founded
-
Finseta Plc is listed in the Catalog, Mail-order Houses sector of the London Stock Exchange with ticker FIN. The last closing price for Finseta was 38.40p. Over the last year, Finseta shares have traded in a share price range of 25.00p to 43.50p.

Finseta currently has 57,417,101 shares outstanding. The market capitalization of Finseta is £22.05 million. Finseta has a price to earnings ratio (PE ratio) of 10.35.

Ask ADVFN Intelligence (AI)

FIN Latest News

More News

Finseta PLC Holding(s) in Company

Finseta PLC 18 December 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...

December 18 2024
RNS Regulatory News

Finseta PLC Grant of Options, PDMR Dealings

Finseta PLC 25 October 2024   25 October 2024   Finseta plc ("Finseta", "the Company" or "the Group")   Grant of Options, PDMR Dealings   Finseta (AIM: FIN), a foreign exchange and payments...

October 25 2024
RNS Regulatory News

Finseta PLC Director/PDMR Shareholding

Finseta PLC 23 September 2024   23 September 2024   Finseta plc ("Finseta", "the Company" or "the Group")   Director/PDMR Shareholding   Finseta (AIM: FIN), a foreign exchange and payments...

September 23 2024
RNS Regulatory News

Finseta maintains growth momentum in line with full-year expectations

Finseta PLC on Tuesday said its half-year revenue has surged, as average transaction values rise and a period of "sig ...

September 10 2024
Alliance News

Finseta PLC Interim Results

Finseta PLC 10 September 2024   Certain information contained within this Announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation...

September 10 2024
RNS Regulatory News

Finseta PLC Notice of Interim Results Presentation

Finseta PLC 14 August 2024   14 August 2024   Finseta plc ("Finseta", "the Company" or "the Group")   Notice of Interim Results Presentation   Finseta (AIM: FIN), a foreign exchange and...

August 14 2024
RNS Regulatory News

DIRECTOR DEALINGS: Jet2 chair buys; Ovoca Bio's old CEO sells to new

The following is a round-up of share dealings by London-listed company directors and managers announced on Monday and ...

July 15 2024
Alliance News

Finseta PLC Director/PDMR Shareholding

Finseta PLC 15 July 2024   15 July 2024   Finseta plc ("Finseta", "the Company" or "the Group")   Director/PDMR Shareholding   Finseta (AIM: FIN), a foreign exchange and payments solutions...

July 15 2024
RNS Regulatory News

Finseta on track to deliver "significant" revenue growth in 2024

Finseta PLC on Tuesday issued a trading update that revealed strong performance over the first six months of the year ...

July 09 2024
Alliance News

Finseta PLC H1 2024 Trading Update

Finseta PLC 09 July 2024   Certain information contained within this Announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU...

July 09 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1411.594202898634.540.534.57277637.23520482DE
43.5103540.5339751734.43745784DE
1212.6666666666737.540.53311782335.82341699DE
267.524.193548387131433115161636.92387484DE
521245.283018867926.543.52522881434.85908038DE
1569.532.75862068972943.55.7522968619.89803251DE
260-23.5-37.903225806562635.7518921520.51996523DE

FIN - Frequently Asked Questions (FAQ)

What is the current Finseta share price?
The current share price of Finseta is 38.50p
How many Finseta shares are in issue?
Finseta has 57,417,101 shares in issue
What is the market cap of Finseta?
The market capitalisation of Finseta is GBP 22.05M
What is the 1 year trading range for Finseta share price?
Finseta has traded in the range of 25.00p to 43.50p during the past year
What is the PE ratio of Finseta?
The price to earnings ratio of Finseta is 10.35
What is the cash to sales ratio of Finseta?
The cash to sales ratio of Finseta is 2.29
What is the reporting currency for Finseta?
Finseta reports financial results in GBP
What is the latest annual turnover for Finseta?
The latest annual turnover of Finseta is GBP 9.65M
What is the latest annual profit for Finseta?
The latest annual profit of Finseta is GBP 2.13M
What is the registered address of Finseta?
The registered address for Finseta is 14-18 COPTHALL AVENUE, LONDON, EC2R 7DJ
What is the Finseta website address?
The website address for Finseta is finseta.com/
Which industry sector does Finseta operate in?
Finseta operates in the CATALOG, MAIL-ORDER HOUSES sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discussion

View Full Feed
JERSEYHAWG JERSEYHAWG 5 minutes ago
Mellon. In regard to your post.

I am not the one making trouble for you. Uour really barking up the wrong tree. I have no idea why you single me out as the troublemaker. Cause I sure as heck ain't. It's plain to see your riled up good. But do me a favor and go pick your fight with wh
LEHNQ
crescentmotor crescentmotor 8 minutes ago
But in the case of Blarcamisine, "sufficient" efficacy is up for debate (given the known data).

Granted, the efficacy of Blarcamesine is still under study but, with the favorable peer review, the winds look favorable. And then what else? There's the ever critical safety question wh
AVXL
benz280c benz280c 8 minutes ago
Incorrect and reviling. Do better, please, in 2025.
GDVM
3331 3331 8 minutes ago
BIEL + DR. OZ + RFK = $$$
BIOELECTRONICS FLAGSHIP PRODUCT - ACTIPATCH - ON DR. OZ:
Dr. Oz devoted a whole program to explaining PEMF Pulsed ElectroMagnetic Field technology - with audience members wearing Actipatches (BIEL's flagship product) - saying it is changing the practice of med
IHuser IHuser 8 minutes ago
imo... easier to ban my narrative than counter it........ never going away AZN


AZN



IHuser
AZN
3331 3331 9 minutes ago
BIEL + DR. OZ + RFK = $$$
BIOELECTRONICS FLAGSHIP PRODUCT - ACTIPATCH - ON DR. OZ:
Dr. Oz devoted a whole program to explaining PEMF Pulsed ElectroMagnetic Field technology - with audience members wearing Actipatches (BIEL's flagship product) - saying it is changing the practice of med
harry crumb harry crumb 9 minutes ago
Oh you are from china an part of this scam,you will go down with ILLR when the SEC investigates the fraud of this company
ILLR
martyDg martyDg 9 minutes ago
Damn, I'mma put you now on my ignore list... I'm tired of seeing you stupid conspiracy theories. Effing clown.
NWBO
BDEZ BDEZ 10 minutes ago
“Everything the government says is a lie, and everything it has is stolen” ~ Nietzsche
harry crumb harry crumb 11 minutes ago
There is no desmis you moron fool! Stop lying. Tiktok is #1 an always will be, how can you lie, your mother must keep you in a closet all day with your noony in your mouth you fool
ILLR
stockinspector stockinspector 12 minutes ago
Dad'burn delightful display of doubtful detractors denying, debating and delirious!
WDLF
gawti88 gawti88 12 minutes ago
I wish you were in this riding with us, unfortunately your crew decided to short it for years and you're going to feel the pain now. When we hit 25c, I hope you don't cry.
CEOS
gawti88 gawti88 13 minutes ago
Wait; small company? lmao... dang 95 + employees isn't a small company.
CEOS
JERSEYHAWG JERSEYHAWG 14 minutes ago
Listen to this bro.
I am on no email lists and don't send email lists to anyone. Why? Cause I don't give a Flynn fuk.

That email, of stuff you said you wrote, and I believe it was sent to me. On a rare occasion zi get something sent to me. For instance this time. I don't mess
LEHNQ
jimr1717 jimr1717 14 minutes ago
This blatant scam is done
ILLR
nowwhat2 nowwhat2 15 minutes ago
Why no be just keep go up yet ?

.
XRPUSD
StayHumble StayHumble 15 minutes ago
w0w SEC🔥catches🎅🏿&👽ArtificiallyDeflating Prices 2Buy Shares"


6, 12, 2023 —

SEC charged investment adviser Sabby Management LLC & managing partner,Hal D. Mintz,w/ fraud in connection w/ a long running scheme involving misrepresenta
HMBL
elks elks 18 minutes ago
Wtf.
TWOH
fuagf fuagf 19 minutes ago
Security risk? Shrug. Trump flips on Tik Tok, because it's good for him.

PatriotTakes 🇺🇸
@patriottakes
Nikki Haley comes out against Trump’s plan to save TikTok, but won’t mention him by name

https://pbs.twimg.com/media/GgeV_fjXkAAgNe7?form
XMaster2023 XMaster2023 21 minutes ago
Roman, there could already be deals cut and the only thing we are waiting for now is approval. I actually believe this is the case and NWBO is under a gag order as BP would not want anything getting out until approval.
NWBO
JJ8 JJ8 23 minutes ago
I am encouraged of what I see of the Histogram in the Weekly Chart showing that a new uptrend appears to be in the process of developing for the AMD share price.

Hopefully that is going to continue... and lead to a share price breakout soon.

We shall see.
AMD
boi568 boi568 24 minutes ago
Anavex has delayed PD in order to wait out the development of a reliable biomarker, which has happened only during the past few months. They may also have understandably diverted some resources towards a successful MAA.
AVXL
boi568 boi568 26 minutes ago
There is no regulatory "sufficiency" test, other than being better than the standard of care, if one exists. The article makes the case that blarcamesine is better than any approved AD drug. The FDA employs a risk/benefit analysis, and you want your drug candidate to more than offset any risks with
AVXL

Your Recent History

LSE
FIN
Finseta
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads